| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mendelian susceptibility to Immune Disorders v0.48 | TBX21 | Zornitza Stark Phenotypes for gene: TBX21 were changed from Inherited susceptibility to mycobacterial disease, MONDO:0019146, TBX21-related to Immunodeficiency 88, MIM# 619630 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.47 | TBX21 | Zornitza Stark Phenotypes for gene: TBX21 were changed from Susceptibility to mycobacterial disease to Inherited susceptibility to mycobacterial disease, MONDO:0019146, TBX21-related | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.46 | TBX21 | Zornitza Stark Marked gene: TBX21 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.46 | TBX21 | Zornitza Stark Gene: tbx21 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.46 | TBX21 | Zornitza Stark Phenotypes for gene: TBX21 were changed from Susceptibility to mycobacterial disease to Susceptibility to mycobacterial disease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.45 | TBX21 | Zornitza Stark Classified gene: TBX21 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.45 | TBX21 | Zornitza Stark Gene: tbx21 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mendelian susceptibility to Immune Disorders v0.41 | TBX21 |
Peter McNaughton gene: TBX21 was added gene: TBX21 was added to Mendelian susceptibility to Immune Disorders. Sources: Literature Mode of inheritance for gene: TBX21 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TBX21 were set to PMID: 33296702 Phenotypes for gene: TBX21 were set to Susceptibility to mycobacterial disease Review for gene: TBX21 was set to AMBER Added comment: Single patient with strong functional validation. Mouse model replicating phenotype. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||